Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone for orbital cellulitis and severe pre-septal cellulitis
ACTRN12622000808741Phase 4Not yet recruiting
- Sponsor
- South Australian Institute of Ophthalmology
- Start
- May 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in orbital cellulitis and periorbital cellulitis comparing Dexamethasone plus standard care with Placebo plus standard care (2 arms). Primary endpoint: Length of hospitalisation. Planned start May 2023; status: not yet recruiting.
02
Drugs
dexamethasone
03
Conditions
orbital cellulitisperiorbital cellulitis
Beyond the preview
Go deeper on ACTRN12622000808741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12622000808741.